Remove Drug Development Remove Leadership Remove Strategy
article thumbnail

Small Language Models (SLMs) have the potential to revolutionise Healthcare AI in addition to LLMs

Lloyd Price

Precision Medicine: SLMs can help identify genetic and environmental factors that contribute to individual health risks, enabling the development of personalised prevention and treatment strategies. Visit [link] Buy Side, Sell Side, Growth & Strategy services for HealthTech Founders, Owners and Investors. Subscribe Today!

article thumbnail

Accenture Invests in QuantHealth to Accelerate Use of AI-Powered Clinical Trial Simulations to Drive Cost-Effective Drug Development

Healthcare IT Today

Drug population and drug protocol fit account for nearly 75% of these failures. By simulating trials at scale, QuantHealth’s platform can lower risks, expedite, and optimize drug development. Petra Jantzer, Ph.D.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Merative formerly IBM Watson Health poised to launch raft of new products in 2025

Lloyd Price

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

HLTH 2024: What are the key talking points likely to be?

Lloyd Price

Investment Strategy: The investment landscape for healthcare startups and emerging technologies. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Climate Change and Health: Examining the health implications of climate change and strategies for sustainable healthcare practices.

article thumbnail

Koneksa Announces Expanded Partnership with SSI Strategy to Scale the Adoption of Digital Biomarkers in Clinical Trials

Digital Health Global

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development. Learn more at koneksahealth.com.

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

The 4 Big Gaps in HealthTech: Funding, Trust, Evidence, Valuation

Lloyd Price

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.